News
News
Below you find news articles, press releases, videos and updates about the LipoCoat progress through the years.
CEMMA and LipoCoat announce partnership for the development of a coated CVC catheter for sustainable infection control
CEMMA and LipoCoat announce partnership for the development of a coated CVC catheter for sustainable infection control Taipei (Taiwan)/ Enschede (the Netherlands), April 20, 2022. CEMMA Medical Company Limited – a leading company in the clinically advanced medical...
LipoCoat is one of 3 winners of the finals of the Extreme Tech Challenge Netherlands & Belgium.
LipoCoat is one of 3 winners of the finals of the Extreme Tech Challenge Netherlands & Belgium. LipoCoat is now invited for the global finals in San Francisco in June 2022! The Extreme Tech Challenge is the world's biggest startup competition that aims to...
LipoCoat’s ISO 13485 Certificate has been extended until March 2025
LipoCoat's ISO 13485 Certificate has been extended until March 2025. Moreover, 'production' has been added to the scope of our ISO 13485 Certificate. The full scope of the ISO 13485 certificate is now 'the design, development and production of bio-inspired coatings...
2021 Key Achievements LipoCoat
Underneath an overview of the Key Achievements in 2021 for LipoCoat.
LipoCoat announced as Best Medical Device Coatings Company of 2020
LipoCoat, a biotech spin-off from the prestigious nanotechnology lab MESA+ of the University of Twente, the Netherlands, has been named the Best Medical Device Coatings Company of 2020 in the Global Healthcare & Pharmaceutical Awards 2020. Bio-inspired and...
€ 1.5 million extra for infection control scale-up LipoCoat
LipoCoat, a biotech spin-off from the renowned nanotechnology institute MESA+ of the University of Twente, the Netherlands, has received additional funding of 1.5 million euros from several investors. The funding is provided by Dutch informal investors, the High Tech...
LipoCoat announced as European Biotech Startup of the year
StartupCity Magazine published its annual list of the “15 Most Promising biotech startups in Europe – 2019”; LipoCoat landed first place. LipoCoat started in 2016 as a spin-off company from the University of Twente, following six years of research into biocompatible...
LipoCoat wins top ten list of most groundbreaking innovations in science
AMSTERDAM, 15 MAY 2019 LipoCoat wins top ten list of most groundbreaking innovations in science LipoCoat is one of the ten winners of the Academic Startup Competition. This was announced by a professional jury in Amsterdam in the presence of State Secretary for...
LipoCoat is proud to announce that our quality management system has been certified according to the standard ISO 13485:2016
LipoCoat is proud to announce that our quality management system has been certified according to the standard ISO 13485:2016 This success is a result of our continuous efforts to provide high quality coating designs for our customers. Therefore developing and...
600,000 euro seed funding Dutch biotech coating startup
LipoCoat BV, a spin-off from the MESA+ nanotechnology institute from the University of Twente, gathered nearly 600.000 euro funding. This milestone was reached with grants from the government, a loan from Redmedtech Ventures and recent investments from LLX2...
LipoCoat celebrated micro-nano startup of the year 2016
The highly promising company LipoCoat, from the Eastern Netherland’s city of Enschede won the second edition of the MicroNano Start-Up of the Year contest. At the closure of the two day International MicroNano Conference in Amsterdam LipoCoat’s Director of Business...
LipoCoat officially founded
The University of Twente startup LipoCoat BV develops unique coatings for e.g. medical devices. The coatings are designed to improve performance, safety and comfort of medical devices but can also be used in, for example, R&D applications. By founding LipoCoat BV,...